Glenn Gormley
Direktor/Vorstandsmitglied bei AMBIT BIOSCIENCES CORP
Aktive Positionen von Glenn Gormley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AMBIT BIOSCIENCES CORP | Direktor/Vorstandsmitglied | 10.11.2014 | - |
University of Delaware | Direktor/Vorstandsmitglied | 17.09.2009 | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Direktor/Vorstandsmitglied | - | - |
Healios N.A., Inc. | Direktor/Vorstandsmitglied | 12.12.2022 | - |
Karriereverlauf von Glenn Gormley
Ehemalige bekannte Positionen von Glenn Gormley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DAIICHI SANKYO CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | - | 31.03.2019 |
Corporate Officer/Principal | 01.04.2019 | - | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Vorstandsvorsitzender | 18.08.2011 | - |
Vorsitzender | 18.08.2011 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 19.08.2011 | - | |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - | - |
Ausbildung von Glenn Gormley
The University of Chicago | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Vereinigtes Königreich | 2 |
Japan | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
DAIICHI SANKYO CO., LTD. | Health Technology |
Private Unternehmen | 7 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
Healios N.A., Inc. |
- Börse
- Insiders
- Glenn Gormley
- Erfahrung